Regeneron Pharmaceuticals
REGN
#252
Rank
A$123.01 B
Marketcap
$1,125
Share price
-0.57%
Change (1 day)
-25.19%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $56.24

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $60.16. In 2022 the company made an earnings per share (EPS) of $65.25 a decrease over its 2021 EPS that were of $123.11.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$56.24-13.81%
2022$65.25-47%
2021$123.11133.36%
2020$52.7569.13%
2019$31.19-14.44%
2018$36.46100.71%
2017$18.1631.78%
2016$13.7838.96%
2015$9.9272.55%
2014$5.75-17.55%
2013$6.97-44.98%
2012$12.67-422.54%
2011-$3.9392.13%
2010-$2.0549.41%
2009-$1.37-15.84%
2008-$1.63-36.88%
2007-$2.58-9.6%
2006-$2.854.12%
2005-$2.74-323.68%
2004$1.22-135.51%
2003-$3.45-24.38%
2002-$4.5656.35%
2001-$2.91187.3%
2000-$1.01-16%
1999-$1.21177.78%
1998-$0.43-35.71%
1997-$0.68-68.42%
1996-$2.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.79-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.62-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.73-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.68-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.02-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.12-91.49%๐Ÿ‡ซ๐Ÿ‡ท France